BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26545132)

  • 1. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
    Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
    Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.
    Saavedra A; Campinha-Bacote N; Hajjar M; Kenu E; Gillani FS; Obo-Akwa A; Lartey M; Kwara A
    Pan Afr Med J; 2017; 27():48. PubMed ID: 28819470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.
    Lartey M; Asante-Quashie A; Essel A; Kenu E; Ganu V; Neequaye A
    Ghana Med J; 2015 Mar; 49(1):7-11. PubMed ID: 26339078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
    Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
    Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.
    Chow A; Tey J; Win MK; Leo YS
    Ann Acad Med Singap; 2012 Dec; 41(12):563-70. PubMed ID: 23303113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
    Mzileni MO; Longo-Mbenza B; Chephe TJ
    Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and loss to follow-up among HAART initiators in rural South Africa.
    MacPherson P; Moshabela M; Martinson N; Pronyk P
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):588-93. PubMed ID: 19012940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
    Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
    HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
    Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and Operational Research: Effect of Universal Access to Antiretroviral Therapy on HIV/AIDS Mortality in Mexico 1990-2011.
    Hernández-Ávila JE; Palacio-Mejía LS; Hernández-Romieu A; Bautista-Arredondo S; Sepúlveda Amor J; Hernández-Ávila M
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e100-8. PubMed ID: 25886921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS-related early mortality in Mexico between 2008 and 2012].
    Silverman-Retana O; Bautista-Arredondo S; Serván-Mori E; Lozano R
    Salud Publica Mex; 2015; 57 Suppl 2():s119-26. PubMed ID: 26545127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of late diagnosis of HIV in Mexico during the HAART era.
    Crabtree-Ramírez B; Caro-Vega Y; Belaunzarán-Zamudio F; Sierra-Madero J
    Salud Publica Mex; 2012 Oct; 54(5):506-14. PubMed ID: 23011502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.